Upgrade to SI Premium - Free Trial

Myriad Genetics (MYGN)

5.56 +0.02 (0.36%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/4/26)

Latest Headlines

TD Cowen Reiterates Hold Rating on Myriad Genetics (MYGN) October 20, 2026 12:11 PM - StreetInsider Myriad Genetics stock surges on $210M prenatal unit sale October 20, 2026 11:26 AM - StreetInsider Piper Sandler Upgrades Myriad Genetics (MYGN) to Neutral October 20, 2026 10:57 AM - StreetInsider Myriad Genetics to sell prenatal testing unit to Labcorp for $210M October 20, 2026 9:03 AM - StreetInsider Form 8-K MYRIAD GENETICS INC For: Oct 19 October 20, 2026 8:36 AM - SEC Filing Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp October 20, 2026 8:30 AM - StreetInsider Myriad Genetics to Release Third Quarter 2026 Financial Results on November 4, 2026 October 15, 2026 4:05 PM - StreetInsider Myriad Genetics (MYGN) PT Raised to $4.50 at TD Cowen October 13, 2026 9:32 AM - StreetInsider Form 8-K MYRIAD GENETICS INC For: Oct 06 October 9, 2026 4:16 PM - SEC Filing Myriad Genetics and SOPHiA Genetics team up on prostate cancer test October 8, 2026 9:01 AM - StreetInsider SOPHiA GENETICS and Myriad Genetics Announce New Collaboration to Advance Prostate Genomic Instability Score Technology October 8, 2026 9:00 AM - PR NewsWire Myriad Genetics and SOPHiA GENETICS Announce New Collaboration to Advance Prostate Genomic Instability Score Technology October 8, 2026 9:00 AM - StreetInsider Myriad Genetics (MYGN) PT Raised to $8 at Craig-Hallum October 2, 2026 9:22 AM - StreetInsider Form 4 MYRIAD GENETICS INC For: Sep 21 Filed by: Wheeler Benjamin Richard September 22, 2026 4:12 PM - SEC Filing Form 4 MYRIAD GENETICS INC For: Sep 16 Filed by: Donnelly Brian J September 18, 2026 4:17 PM - SEC Filing Form 4 MYRIAD GENETICS INC For: Sep 16 Filed by: Sikri Vishal September 17, 2026 4:34 PM - SEC Filing Form 3 MYRIAD GENETICS INC For: Sep 16 Filed by: Sikri Vishal September 17, 2026 4:31 PM - SEC Filing Form 8-K MYRIAD GENETICS INC For: Sep 15 September 16, 2026 8:01 AM - SEC Filing Myriad Genetics promotes Vishal Sikri to EVP of commercial September 16, 2026 8:00 AM - StreetInsider Myriad Genetics Appoints Vishal Sikri Executive Vice President - Commercial September 16, 2026 8:00 AM - StreetInsider UBS Assumes Myriad Genetics (MYGN) at Neutral September 9, 2026 6:08 AM - StreetInsider Piper Sandler Double Downgrades Myriad Genetics (MYGN) to Underweight, 'Major Strategic Action Likely Needed' September 1, 2026 3:36 AM - StreetInsider Myriad Genetics to Present at 2026 Wells Fargo Healthcare Conference August 27, 2026 9:05 AM - Globe NewsWire Myriad Genetics (MYGN) PT Lowered to $2.50 at Jefferies August 20, 2026 3:55 PM - StreetInsider Myriad Genetics (MYGN) PT Lowered to $3 at Stephens August 18, 2026 6:31 AM - StreetInsider Form 4 MYRIAD GENETICS INC For: Aug 16 Filed by: Wheeler Benjamin Richard August 17, 2026 4:26 PM - SEC Filing Form SCHEDULE 13G/A MYRIAD GENETICS INC Filed by: GLENVIEW CAPITAL MANAGEMENT, LLC August 14, 2026 5:00 PM - SEC Filing Form SCHEDULE 13G MYRIAD GENETICS INC Filed by: Vestal Point Capital, LP August 14, 2026 4:16 PM - SEC Filing Form SCHEDULE 13G MYRIAD GENETICS INC Filed by: STATE STREET CORP August 7, 2026 10:10 AM - SEC Filing Myriad Genetics (MYGN) PT Lowered to $3 at Wells Fargo August 3, 2026 7:08 AM - StreetInsider Myriad Genetics (MYGN) PT Lowered to $4 at TD Cowen July 31, 2026 9:09 AM - StreetInsider Form 10-Q MYRIAD GENETICS INC For: Jun 30 July 31, 2026 8:02 AM - SEC Filing Myriad Genetics (MYGN) Misses Q2 EPS by 19c ; Offers Guidance July 31, 2026 1:08 AM - StreetInsider Form 8-K MYRIAD GENETICS INC For: Jul 30 July 30, 2026 4:08 PM - SEC Filing Myriad Genetics cuts 2026 revenue guidance after Q2 miss July 30, 2026 4:07 PM - StreetInsider Myriad Genetics Reports Second Quarter 2026 Financial Results; Deploying New Initiatives Focused on Driving Increased Efficiency, Productivity and Scalability July 30, 2026 4:05 PM - StreetInsider Myriad Genetics to Release Second Quarter 2026 Financial Results on July 30, 2026 July 23, 2026 9:05 AM - StreetInsider Full Article List